Encapsulation and release of plasminogen activator from biodegradable magnetic microcarriers.
暂无分享,去创建一个
A. Rosengart | M. Finck | Yumei Xie | M. Kaminski | Haitao Chen | Yumei Xie | C. Mertz | Haitao Chen | Michael D. Kaminski | Carol J. Mertz | Martha R. Finck | Axel J. Rosengart
[1] J. Loscalzo,et al. New Therapeutic Agents in Thrombosis and Thrombolysis , 2009 .
[2] Robert Langer,et al. Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[3] Erwin K. Kastrup,et al. Drug facts and comparisons , 1977 .
[4] D. Christensen,et al. The role of cavitation in acoustically activated drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[5] J. Leach,et al. Encapsulation of a plasminogen activator speeds reperfusion, lessens infarct and reduces blood loss in a canine model of coronary artery thrombosis , 2004, Thrombosis and Haemostasis.
[6] S. Phillips,et al. IV tissue plasminogen activator use in acute stroke: Experience from a statewide registry , 2006, Neurology.
[7] J. A. Ritter,et al. Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent: 1. Parametric study with single wire correlation , 2004 .
[8] Ruxandra Gref,et al. Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. , 1998, Journal of biomedical materials research.
[9] Michael D. Kaminski,et al. Magnetically guided plasminogen activator-loaded designer spheres for acutestroke lysis. , 2007 .
[10] M. Hennerici,et al. Ultrasound in the treatment of ischaemic stroke , 2003, The Lancet Neurology.
[11] E. O’Rear,et al. Thrombolysis Using Liposomal-Encapsulated Streptokinase: An In Vitro Study , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[12] K. Ulgen,et al. The stability of enzymes after sonication , 2000 .
[13] L. Goldfrank. Goldfrank's Toxicologic emergencies , 1986 .
[14] A. Alexandrov. Ultrasound Identification and Lysis of Clots , 2004, Stroke.
[15] Marc Fatar,et al. Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. , 2002, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.
[16] Giles Richardson,et al. Mathematical modelling of magnetically targeted drug delivery , 2005 .
[17] D. Crommelin,et al. Thrombolytic Treatment with Tissue-type Plasminogen Activator (t-PA) Containing Liposomes in Rabbits: a Comparison with Free t-PA , 1995, Thrombosis and Haemostasis.
[18] V. Torchilin,et al. Magnetically driven thrombolytic preparation containing immobilized streptokinase-targeted transport and action. , 1988, Haemostasis.
[19] R. K. Rana,et al. Release of Human Serum Albumin from Poly(lactide-co-glycolide) Microspheres , 1990, Pharmaceutical Research.
[20] G. Blümel,et al. [Mechanisms of fibrilolysis activation and fibrinolysis inhibition]. , 1978, Die Medizinische Welt.
[21] V. Yang,et al. Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[22] W Wang,et al. Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.
[23] Michael D. Kaminski,et al. Preparation and characterization of hydrophobic superparamagnetic magnetite gel , 2006 .
[24] D. Christensen,et al. Factors affecting acoustically triggered release of drugs from polymeric micelles. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[25] Robert Langer,et al. Polymeric controlled drug delivery , 1988 .
[26] J. Leach,et al. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase , 2003, Thrombosis and Haemostasis.
[27] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[28] T. Chung,et al. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives , 2006, Journal of microencapsulation.